In this podcast, Steven Grinspoon, MD, discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD. More at: www.consultant360.com/gastroenterology

In this podcast, Steven Grinspoon, MD, discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD. More at: www.consultant360.com/gastroenterology

In this podcast,&nbsp;Steven Grinspoon, MD, discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD. More at: www.consultant360.com/gastroenterology

Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD

Sign up to save your podcasts

Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD

Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast